ThermoGenesis Holdings, Inc. develops, commercializes and markets a range of automated technologies for CAR-T and other cell-based therapies. The Company currently markets a full suite of solutions for automated clinical biobanking, point-of-care applications, and automation for immuno-oncology, including its semi-automated, functionally-closed CAR-TXpress⢠platform, which streamlines the manufacturing process for the emerging CAR-T immunotherapy market.
Website: | thermogenesis.com/ |
Email: | |
Main Phone: | +1 916 858-5100 |
Address: | 2711 Citrus Road |
State: | CA |
City / Town: | Rancho Cordova |
Country: | US |
Postal Code: | 95742 |
Exchange: | NSC |
CEO: | Xiaochun Chris Xu |
Employees: | 53 |
NAICS: | Surgical Appliance and Supplies Manufacturing(339113) |
Last Price N/A | Change $ N/A | Change % N/A | Tick N/A |
Bid N/A | Bid Size N/A | Ask N/A | Ask Size N/A |
Open N/A | High N/A | Low N/A | Prev Close N/A |
Last Trade | Volume N/A | 52 Wk Hi N/A | 52 Wk Low N/A |
Market Cap N/A | Ex-Div Date N/A | Div Rate N/A | Yield N/A |
Shares N/A | EPS (TTM) N/A | PE Ratio N/A | Exchange N/A |
|
|
Last 3 Mo | Last 12 Mo | |
---|---|---|
Number of Insider Trades | 0 | 0 |
Number of Buys | 0 | 0 |
Number of Sells | 0 | 0 |
Net Activity | 0 | 0 |
Last 10 Buys | Shares |
---|---|
Joseph Thomis | 1,000 |
J. Melville Engle | 1,000 |
Jorge Artiles | 1,000 |
Jorge Artiles | 1,000 |
J. Melville Engle | 1,000 |
Patrick J. McEnany | 1,000 |
J. Melville Engle | 1,000 |
Patrick J. McEnany | 1,000 |
Last 10 Sell | Shares |
---|---|
Kenneth Harris | 1,000 |
Kenneth Harris | 1,000 |
Kenneth Harris | 1,000 |
Kenneth Harris | 1,000 |
Kenneth Harris | 1,000 |
Kenneth Harris | 1,000 |
Matthew T. Plavan | 1,000 |
Matthew T. Plavan | 1,000 |
Current | 1 Week Ago | 2 Weeks Ago | 3 Weeks Ago | |
---|---|---|---|---|
High Target Price Estimate | 7.5 | 7.5 | 7.5 | 7.5 |
Low Target Price Estimate | 7.5 | 7.5 | 7.5 | 7.5 |
Mean Target Price Estimate | 7.5 | 7.5 | 7.5 | 7.5 |
Standard Deviation | 0 | 0 | 0 | 0 |
Date of Most Recent Estimate | 10/03/19 | 10/03/19 | 10/03/19 | 10/03/19 |
Form Type | Form Description | Pages | Date |
---|---|---|---|
8-K | Current report pursuant to Section 13 or 15(d) | 4 | 2019-10-31 |
8-K | Current report pursuant to Section 13 or 15(d) | 3 | 2019-10-22 |
8-K | Current report pursuant to Section 13 or 15(d) | 26 | 2019-10-22 |
8-K/A | [Amend]Current report pursuant to Section 13 or 15(d) | 1 | 2019-09-24 |
4 | Statement of changes in beneficial ownership of securities | 1 | 2019-09-18 |
4 | Statement of changes in beneficial ownership of securities | 1 | 2019-09-18 |
4 | Statement of changes in beneficial ownership of securities | 1 | 2019-09-18 |
S-8 | Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | 4 | 2019-09-12 |
8-K | Current report pursuant to Section 13 or 15(d) | 21 | 2019-09-10 |
8-K | Current report pursuant to Section 13 or 15(d) | 2 | 2019-09-06 |
Current | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|
Strong Buy | 1 | 1 | 1 | 1 |
Moderate Buy | 0 | 0 | 0 | 0 |
Hold | 0 | 0 | 0 | 0 |
Moderate Sell | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 |
Mean Rec. | 1 | 1 | 1 | 1 |